Claudine Bruck
CIK 1733680 · last filed 2025-11-12
Claudine Bruck is a corporate insider who has filed 17 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider exercised options covering $1000 of ANVS on Nov 12, 2025. Across all open-market trades the lifetime net is +$14.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $24.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.4K
2
17
$14.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANVS | Director | 13,709 | $1.78 | $24.4K | $9.8K | 11 | 2025-11-12 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 16,519 | $0.00 | $2 | $4.9K | 6 | 2021-07-07 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-12 | ANVS | Exer (M) | +7,142 | $1000 | EDGAR |
| 2024-07-03 | ANVS | Grant (A) | — | $0 | EDGAR |
| 2023-11-22 | ANVS | Other (J) | — | $0 | EDGAR |
| 2023-11-21 | ANVS | Grant (A) | +1,000 | $6.1K | EDGAR |
| 2023-04-11 | ANVS | Grant (A) | +500 | $6.3K | EDGAR |
| 2023-01-20 | ANVS | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | ANVS | Grant (A) | — | $0 | EDGAR |
| 2021-10-13 | ANVS | Buy (P) | +181 | $5.0K | EDGAR |
| 2021-07-09 | ANVS | Grant (A) | — | $0 | EDGAR |
| 2021-07-07 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +3,969 | $0 | EDGAR |